Advertisement

PSE-standardisierte Verlaufsdaten zur Minussymptomatik

  • K. Maurer

Zusammenfassung

Die Weltgesundheitsorganisation (WHO) hat beginnend in den 70er Jahren drei multizentrische Schizophrenieverlaufsstudien geplant und koordiniert, nämlich
  • die International Pilot Study of Schizophrenia (WHO 1973, 1979),

  • die Determinants of Outcome Studie (Sartorius et al. 1986; Häfner 1987; Jablensky 1987 a, b) sowie

  • die Behinderungsstudie (Jablensky et al. 1980; Canavan et al. 1984).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abrams R, Taylor MA (1978) A rating scale for emotional blunting. Am J Psychiatry 135: 226–229.PubMedGoogle Scholar
  2. Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39: 784–788.PubMedCrossRefGoogle Scholar
  3. Biehl H, Maurer K, Jung E (1985) Entwicklung von Behinderungen bei Schizophrenen — Erfassung, Differenzierung und Vorhersage. Ergebnisbericht des BMFT-Projekts 01 ZX072/6.Google Scholar
  4. Biehl H, Maurer K, Jung E, Krumm B, Schubart C (1986a) Neuere Aspekte der Behinderungsforschung bei Schizophrenen — Praktische Anwendung, Versorgung und Klassifikation. Ergebnisbericht zum GSF/BFMT-Projekt 0701608 6.Google Scholar
  5. Biehl H, Maurer K, Schubart C, Krumm B, Jung E (1986b) Prediction of outcome and utilization of medical services in a prospective five-year follow up study. Eur Arch Psychiatry Neurol Sci 236: 139–147.PubMedCrossRefGoogle Scholar
  6. Biehl H, Maurer K, Jung E, Krumm B, Schubart C (1987) Zum „natürlichen Verlauf“ schizophrener Erkrankungen — Begriff und Beispiele zum beobachteten Verhalten in einer prospektiven Studie. Nervenheilkunde 6: 153–163.Google Scholar
  7. Biehl H, Maurer K, Jung E, Krüger G, Schubart C (1988) Reported symptoms in schizophrenic patients within five years of the onset of illness. In: Dencker SJ, Kulhanek F (eds) Treatment resistance of schizophrenia. Vieweg, Braunschweig.Google Scholar
  8. Biehl H, Maurer K, Jablensky A, Cooper JE, Tomov T (1989a) The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept. Br J Psychiatry (Suppl) 155: 68–70.Google Scholar
  9. Biehl H, Maurer K, Jung E, Krumm B (1989b) The WHO Psychological Impairments Rating Schedule (WHO/PIRS). II. Impairments in schizophrenics in cross-sectional and longitudinal perspective — The Mannheim experience in two independent samples. Br J Psychiatry (Suppl) 155: 71–77.Google Scholar
  10. Blashfield RK (1984) The classification of psychopathology. Neo-Kraepelinian and quantiative approaches. Plenum Press, New York.Google Scholar
  11. Canavan K, Schwarz R, Wiersma D, Jablensky A, Biehl H (1984) Assessment and reduction of psychiatric disability. A selective review of legislation in seven countries participating in a WHO study. Int Digest Health Legislat 35: 509–549.Google Scholar
  12. Häfner H (1987) Epidemiology of schizophrenia. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 47–74.CrossRefGoogle Scholar
  13. Iager AC, Kirch DG, Wyatt RJ (1985) A negative symptom rating scale. Psychiatric Res 16: 27–36.CrossRefGoogle Scholar
  14. Jablensky A (1987a) Epidemiology of schizophrenia. Paper prepared for the Mental Health Foundation Conference “New Initiatives in Schizophrenia Research”, Balliol College, Oxford, Sept. 2nd-4th 1987.Google Scholar
  15. Jablensky A (1987b) Multicultural studies and the nature of schizophrenia: a review. J R Soc Med 80: 162–167.PubMedGoogle Scholar
  16. Jablensky A, Schwarz R, Tomov J (1980) WHO-Collaborating Study on Impairments and Disabilities Associated with Schizophrenic Disorders. A Preliminary Communication: Objectives and Models. In: Strömgren E, Dupont A, Nielsen JA (eds) Epidemiological research as basis for the organization of extramural psychiatry. Acta Psychiatr Scand (Suppl 285) 62: 152–163.Google Scholar
  17. Katschnig H (1988) Wert und Unwert der operationalisierten Diagnostik für die biologischpsychiatrische Forschung. In: Beckmann H, Laux G (Hrsg) Biologische Psychiatrie. Synopsis 1986/87. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  18. Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 13: 261–273.PubMedGoogle Scholar
  19. Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55: 299–308.PubMedCrossRefGoogle Scholar
  20. Krüger G, Biehl H, Maurer K, Jung E, Schubart C (1985) 5-Jahres-Verlauf eines Samples ersterkrankter Schizophrener — Symptomatologie. In: Reimer F (Hrsg) Prognose und Prophylaxe in der Psychiatrie, 16. Weinsberger Kolloquium. Weissenhof, Weinsberg.Google Scholar
  21. Krüger G, Biehl H, Maurer K, Jung E, Bauer-Schubart C (1988) Longitudinale Symptomveränderungen bei schizophrenen Patienten über 5 Jahre nach Krankheitsbeginn. In: Bender W, Dencker SJ, Kulhanek F (eds) Schizophrene Erkrankungen. Theapie, Therapieresistenz — eine Standortbestimmung. Vieweg, Braunschweig.Google Scholar
  22. Lewine RRJ, Fogg L, Meltzer HY (1983) Assessment of negative and positive symptoms in schizophrenia. Schizophr Bull 9: 368–376.PubMedGoogle Scholar
  23. Maurer K, Biehl H, Kühner C, Löffler W (1989) On the way to expert systems. Comparing DSM-III computer diagnoses with CATEGO (ICD) diagnoses in depressive and schizophrenic patients. Eur Arch Psychiatry Neurol Sci 239: 127–132.PubMedCrossRefGoogle Scholar
  24. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10: 799–812.Google Scholar
  25. Overall JE, Hollister LE, Pichot P (1967) Major psychiatric disorders: A four-dimensional model. Arch Gen Psychiatry 16: 146–151.PubMedCrossRefGoogle Scholar
  26. Pogue-Geile MF, Harrow M (1984) Negative and positive symptoms in schizophrenia and depression: A follow-up. Schizophr Bull 10: 371–385.PubMedGoogle Scholar
  27. Pogue-Geile MF, Zubin J (1988) Negative symptomatology and schizophrenia: a conceptual and empirical review. Int J Ment Health 16: 3–45.Google Scholar
  28. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. Psychol Med 16: 909–928.PubMedCrossRefGoogle Scholar
  29. Schubart C, Krumm B, Biehl H, Schwarz R (1986a) Measurement of social disability in a schizophrenic patient group. Soc Psychiatry 21: 1–9.PubMedCrossRefGoogle Scholar
  30. Schubart C, Schwarz R, Krumm B, Biehl H (1986b) Schizophrenie und soziale Anpassung. Springer, Berlin Heidelberg New York Tokyo.CrossRefGoogle Scholar
  31. Venables PH (1957) A short scale for rating “activity-withdrawal” in schizophrenics. J Ment Sci 103: 197–199.PubMedGoogle Scholar
  32. Wing JK (1961) A simple and reliable subclassification of chronic schizophrenia. J Ment Sci 107: 862–875.PubMedGoogle Scholar
  33. Wing JK (1984) Defining the data base. World Psychiatric Association, Regional Symposium, Helsinki, Juni 18-21, 1084. Book of Abstracts, p 10.Google Scholar
  34. Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms. Cambridge University Press, London.Google Scholar
  35. World Health Organization (1973) The international pilot study of schizophrenia, vol 1, WHO, Geneva.Google Scholar
  36. World Health Organization (1979) Mental disorders: Glossary and guide to their classification in accordance with the Ninth Revision of the International Classification of Diseases, WHO Geneva.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • K. Maurer

There are no affiliations available

Personalised recommendations